Companies Cryptocurrencies
OPKO Health Inc
OPKO Health Inc
Exchange: Nasdaq Global Select
IPO Date: 02/11/1995
CEO: Dr. Phillip Frost
Diagnostics & Research Healthcare 🔗
  • OPK
  • 2.53
  • 1725330944
    market cap
  • -0.05999994
If you bought

shares of OPKO Health Inc (OPK) on
You would have made
Old Price $12 Current Price $12

OPKO Health, Inc. engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 5,690 full-time employees. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women’s Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.

Address: 4400 Biscayne Blvd Miami FLORIDA 33137

Stay updated.